GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Institutional Ownership

Alzinova AB (OSTO:ALZ) Institutional Ownership : 0.01% (As of Apr. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Alzinova AB's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Alzinova AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Alzinova AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Alzinova AB Institutional Ownership Historical Data

The historical data trend for Alzinova AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Institutional Ownership Chart

Alzinova AB Historical Data

The historical data trend for Alzinova AB can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01

Alzinova AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Alzinova AB (OSTO:ALZ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Institutional Ownership
Comparable Companies
OSTO:ELIC OSTO:BIOVIC B OSTO:NXTCL OSTO:ISOFOL XSAT:CESSA OSTO:ACE OSTO:SPRINT OSTO:LIPUM OSTO:SIMRIS B OSTO:ZICC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
78D:Germany
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Website
https://www.alzinova.com
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is also engaged in development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody. The product is in clinical development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB (OSTO:ALZ) Headlines

No Headlines